J&J says halting development of Botox rival

Home › J&J says halting development of Botox rival

Johnson & Johnson said on Friday it was ending its efforts to bring to market a rival drug to Allergan Inc's popular Botox anti-wrinkle treatment.

08.07	Hurricane Beryl Public Advisory Number 39A
08.07	Farm Progress America, July 8, 2024
08.07	Atlantic Tropical Weather Outlook
08.07	Eastern North Pacific Tropical Weather Outlook
08.07	Summary for Hurricane Beryl (AT2/AL022024)
08.07	Carlsberg to buy Robinsons squash maker Britvic
08.07	Hurricane Beryl Update Statement
08.07	Summary for Hurricane Beryl (AT2/AL022024)
More »

je.st